The long term goals of this project are to understand the the detailed interactions between drugs and the heme group of cytochrome P450s, in order to better manage drug-drug interactions. Cytochrome P50s (CYPs) are heme-containing enzymes that dominate drug metabolism and play a critical role in drug-drug interactions. In addition CYPs are drug targets for breast cancer, fungal infections and infectious diseases. Nearly all drugs targeted to CYPs, and most new drugs with other targets that are metabolized by CYPs, Include nitrogen heterocycles. These and other nitrogen-containing fragments are thought to provide the critical interactions with the CYPs that result in inhibitory drug interactions. Interactions ofthe nitrogen fragments with the CYP heme cofactor results in spectral changes that have historically been interpreted as direct heme-nitrogen ligation, which is expected to result in a high reduction potential that prevents catalytic activity;Such interactions are a design component of CYP-targeted dnjgs and they are avoided in other drugs to minimize drug interactions. However, our recent discovery that some nitrogen-containing drugs do not ligate directly to the heme, but instead they hydrogen bond to water remaining on the heme significantly changes the historical paradigm. The resulting water-bridged drug complexes, once thought to be solely inhibitory, are catalytically metabolized. The anti-hepatitus C dmg Telaprevir is candidate for this new binding mode and will be a focus of research. Further Understanding of the factors that determine the formation of the complexes, and the their functional properties, is necessary to engineer undesired drug-drug interactions and to optimize drug design of CYP-targeted therapeutics.
The aims of this project are to determine the scope of these interactions among various drugs and cYP isoforms, to determine the fucntional properties of the. water-bridged complexes that are indentified, and to relate these findigns to the behavior of the putative water-bridged Telaprevir-CYP3A4 complex.
Drug metabolism by Cytochrome P45ps (CYPs) leads to undesirable drug interactions. A better understanding of the way that different types of drugs interact with the heme cofactor of CYPs will improve our ability to predict or control drug interactions.
| Lockart, Molly M; Rodriguez, Carlo A; Atkins, William M et al. (2018) CW EPR parameters reveal cytochrome P450 ligand binding modes. J Inorg Biochem 183:157-164 |
| Guo, Zhijun; Sevrioukova, Irina F; Denisov, Ilia G et al. (2017) Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria. Cell Chem Biol 24:1259-1275.e6 |
| Barnaba, Carlo; Humphreys, Sara C; Barden, Adam O et al. (2016) Substrate Dependent Native Luminescence from Cytochromes P450 3A4, 2C9, and P450cam. J Phys Chem B 120:3038-3047 |
| McClary, Wynton D; Sumida, John P; Scian, Michele et al. (2016) Membrane Fluidity Modulates Thermal Stability and Ligand Binding of Cytochrome P4503A4 in Lipid Nanodiscs. Biochemistry 55:6258-6268 |
| Treuheit, Nicholas A; Redhair, Michelle; Kwon, Hyewon et al. (2016) Membrane Interactions, Ligand-Dependent Dynamics, and Stability of Cytochrome P4503A4 in Lipid Nanodiscs. Biochemistry 55:1058-69 |
| Scott, Emily E; Wolf, C Roland; Otyepka, Michal et al. (2016) The Role of Protein-Protein and Protein-Membrane Interactions on P450 Function. Drug Metab Dispos 44:576-90 |
| Trahey, Meg; Li, Mavis Jiarong; Kwon, Hyewon et al. (2015) Applications of Lipid Nanodiscs for the Study of Membrane Proteins by Surface Plasmon Resonance. Curr Protoc Protein Sci 81:29.13.1-16 |
| Cruce, Alex A; Lockart, Molly; Bowman, Michael K (2015) Pulsed EPR in the Study of Drug Binding in Cytochrome P450 and NOS. Methods Enzymol 563:311-40 |
| Conner, Kip P; Cruce, Alex A; Krzyaniak, Matthew D et al. (2015) Drug modulation of water-heme interactions in low-spin P450 complexes of CYP2C9d and CYP125A1. Biochemistry 54:1198-207 |
| Atkins, William M (2015) Biological messiness vs. biological genius: Mechanistic aspects and roles of protein promiscuity. J Steroid Biochem Mol Biol 151:3-11 |
Showing the most recent 10 out of 12 publications
